Hematology/Oncology News

CHICAGO — Hormone therapy use among menopausal women has fallen to just 1.8% as of 2023, data show, despite evidence and clinical guidance suggesting HT is safe and effective for most women for bothersome menopausal symptoms.

A “simple model” known as ATLAS can help physicians detect recurrent cutaneous melanoma through symptom review, according to researchers.

Patients with atrial fibrillation needing stroke prevention assigned to abelacimab had very low rates of bleeding during invasive procedures, according to new data from the AZALEA-TIMI 71 trial.

The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection.

A multi-institutional team of researchers developed an AI model designed to predict which patients with breast cancer are most likely to experience chronic pain.

A real-world evaluation of axicabtagene ciloleucel for individuals with relapsed or refractory large B-cell lymphoma showed 5-year OS, PFS and disease-specific survival rates comparable to those observed in clinical trials.

The combination of a ketogenic diet and an experimental MNK inhibitor may be able to shrink pancreatic cancer tumors, according to preliminary study findings.

A first-in-human clinical trial will assess the safety of a personalized vaccine to treat diffuse hemispheric glioma, an aggressive brain tumor.

Women oncologists reported a multitude of barriers to family building, including dysfunctional maternity leave and poor education on infertility risk, according to results of a qualitative study published in Cancer.

Veterans experience higher prevalence rates of skin cancer, especially melanoma, and psoriasis compared with nonveterans, according to a study.